Ionis Pharmaceuticals

Ionis Revenue Growth to Surge with 2026 Launch of Olezarsen in SHTG

伊奥尼斯制药

Ionis Pharmaceuticals: Bollinger Bands Narrowing, KDJ Death Cross in 15min Chart

Ionis Pharmaceuticals MACD Death Cross, KDJ Death Cross on 15-Minute Chart

Ionis Pharmaceuticals' 15min chart shows Bollinger Bands Narrowing, KDJ Death Cross triggered.

Ionis Pharmaceuticals: Valuation Reassessed After Strong Shareholder Returns

Catalyst<ul> <li>Most analysts rate IONS Buy, showing broad institutional optimism.</li> <li>Fund flow trends indicate positive net inflows from medium and extra-large orders.</li></ul>Risk<ul> <li>Fund flow trends show negative net outflows from small and large orders.</li> <li>Technical indicators suggest market volatility with mixed signals from long upper and lower shadows.</li></ul>

Key Factors

Ionis Pharmaceuticals (IONS) has seen its stock price rise 1.7% in one day and 149.8% over the past year amid strong revenue growth and positive expectations for Tryngolza and Donidalorsen.

IONS News